trial · primary record
HRS4642
Pancreatic Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2027-05 |
| Primary endpoint | The maximum plasma concentration (Cmax) |
| Registry ID | NCT07906691 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:16.467Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07906691
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.